IL6 and infection: Collectively, these results suggest that the four day administration of rIL-6 does not completely replicate the response of a wt IL-6 replete mouse and instead is responsible for a change in the make-up of the infiltrating cell population following infection (day 10) that is responsible for the control in the severity of late stage chronic disease.